285 related articles for article (PubMed ID: 32745483)
21. Role of high expression of IL-9 in prognosis of CLL.
Chen N; Lv X; Li P; Lu K; Wang X
Int J Clin Exp Pathol; 2014; 7(2):716-21. PubMed ID: 24551294
[TBL] [Abstract][Full Text] [Related]
22. [Detection of puma mRNA levels by real-time quantitative RT-PCR in chronic lymphocytic leukemia and its clinical significance].
Zhu HJ; Xu W; Cao X; Fang C; Zhu DX; Dong HJ; Wang DM; Qiao C; Miao KR; Liu P; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):843-8. PubMed ID: 20723285
[TBL] [Abstract][Full Text] [Related]
23. Aberrant expression profile of miR-32, miR-98 and miR-374 in chronic lymphocytic leukemia.
Rahimi Z; Ghorbani Z; Motamed H; Jalilian N
Leuk Res; 2021 Dec; 111():106691. PubMed ID: 34455196
[TBL] [Abstract][Full Text] [Related]
24. Association between immunoglobulin heavy-chain variable region mutational status and isolated favorable baseline genomic aberrations in chronic lymphocytic leukemia.
Sandoval-Sus JD; Chavez JC; Dalia S; Naqvi SMH; Talati C; Nodzon L; Kharfan-Dabaja MA; Pinilla-Ibarz J
Leuk Lymphoma; 2018 Jan; 59(1):59-68. PubMed ID: 28641468
[TBL] [Abstract][Full Text] [Related]
25. The prognostic role of CXCR3 expression by chronic lymphocytic leukemia B cells.
Ocaña E; Delgado-Pérez L; Campos-Caro A; Muñóz J; Paz A; Franco R; Brieva JA
Haematologica; 2007 Mar; 92(3):349-56. PubMed ID: 17339184
[TBL] [Abstract][Full Text] [Related]
26. Most morphologic features in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) do not reliably predict underlying FISH genetics or immunoglobulin heavy chain variable region somatic mutational status.
Garcia CF; Hunt KE; Kang H; Babb A; Gale JM; Vasef MA; Reichard KK
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):119-27. PubMed ID: 19826250
[TBL] [Abstract][Full Text] [Related]
27.
Habashy DM; Eissa DS; Aboelez MM
Turk J Haematol; 2018 Aug; 35(3):168-174. PubMed ID: 28884705
[TBL] [Abstract][Full Text] [Related]
28. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
[TBL] [Abstract][Full Text] [Related]
29. A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL.
Nichols EM; Jones R; Watson R; Pepper CJ; Fegan C; Marchbank KJ
Oncotarget; 2015 Oct; 6(32):32669-80. PubMed ID: 26452134
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia.
Zhou K; Yi S; Yu Z; Li Z; Wang Y; Zou D; Qi J; Zhao Y; Qiu L
Leuk Lymphoma; 2012 Jun; 53(6):1155-61. PubMed ID: 22145958
[TBL] [Abstract][Full Text] [Related]
31. CD38 as a prognostic factor in B cell chronic lymphocytic leukaemia (B-CLL): comparison of three approaches to analyze its expression.
Boonstra JG; van Lom K; Langerak AW; Graveland WJ; Valk PJ; Kraan J; van 't Veer MB; Gratama JW
Cytometry B Clin Cytom; 2006 May; 70(3):136-41. PubMed ID: 16568475
[TBL] [Abstract][Full Text] [Related]
32. Lipoprotein lipase mRNA expression in whole blood is a prognostic marker in B cell chronic lymphocytic leukemia.
Van Bockstaele F; Pede V; Janssens A; Callewaert F; Offner F; Verhasselt B; Philippé J
Clin Chem; 2007 Feb; 53(2):204-12. PubMed ID: 17158192
[TBL] [Abstract][Full Text] [Related]
33. High expression of hematopoietic cell specific Lyn substrate-1 (HS1) predicts poor survival of B-cell chronic lymphocytic leukemia patients.
Butrym A; Majewski M; Dzietczenia J; Kuliczkowski K; Mazur G
Leuk Res; 2012 Jul; 36(7):876-80. PubMed ID: 22333038
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
[TBL] [Abstract][Full Text] [Related]
35. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.
Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607
[TBL] [Abstract][Full Text] [Related]
36. Small RNA-seq and clinical evaluation of tRNA-derived fragments in multiple myeloma: Loss of mitochondrial i-tRF
Soureas K; Papadimitriou MA; Malandrakis P; Papanota AM; Adamopoulos PG; Ntanasis-Stathopoulos I; Liacos CI; Gavriatopoulou M; Sideris DC; Kastritis E; Dimopoulos MA; Scorilas A; Terpos E; Avgeris M
Br J Haematol; 2024 May; 204(5):1790-1800. PubMed ID: 38414235
[TBL] [Abstract][Full Text] [Related]
37. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
Bomben R; Dal-Bo M; Benedetti D; Capello D; Forconi F; Marconi D; Bertoni F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Luciano F; Sozzi E; Cattarossi I; Zucchetto A; Rossi FM; Bulian P; Zucca E; Nicoloso MS; Degan M; Marasca R; Efremov DG; Del Poeta G; Gaidano G; Gattei V
Clin Cancer Res; 2010 Jan; 16(2):620-8. PubMed ID: 20068100
[TBL] [Abstract][Full Text] [Related]
38. CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia.
Sivina M; Hartmann E; Kipps TJ; Rassenti L; Krupnik D; Lerner S; LaPushin R; Xiao L; Huang X; Werner L; Neuberg D; Kantarjian H; O'Brien S; Wierda WG; Keating MJ; Rosenwald A; Burger JA
Blood; 2011 Feb; 117(5):1662-9. PubMed ID: 21115978
[TBL] [Abstract][Full Text] [Related]
39. Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features.
Vrbacky F; Smolej L; Vroblova V; Pekova S; Hrudkova M; Cervinka M; Pecka M; Krejsek J; Maly J
Hematology; 2010 Aug; 15(4):210-4. PubMed ID: 20670479
[TBL] [Abstract][Full Text] [Related]
40. NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.
Yang YQ; Tian T; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Wang L; Fan L; Li JY; Xu W
BMC Cancer; 2018 Oct; 18(1):1009. PubMed ID: 30348117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
